Back to Authors

Hatami, Parvaneh

0000-0002-3531-2907

Mayo Clinic

Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Citations 6

Clinical efficacy of mychophenolate mofetil in treating lichen planopilaris

Dermatologic Therapy | June 8, 2022 | Volume: 35 | Issue: 8 | Pages: No page available

10.1111/dth.15625 | PMID 35674693

Demographic and clinical characteristics of hospitalized psoriasis patients

Journal of Cosmetic Dermatology | June 6, 2022 | Volume: 21 | Issue: 11 | Pages: 6476-6478

10.1111/jocd.15144 | PMID 35665588

New‐onset pemphigus foliaceus following SARS‐CoV‐2 infection and unmasking multiple sclerosis: A case report

Clinical Case Reports | June 3, 2022 | Volume: 10 | Issue: 6 | Pages: No page available

10.1002/ccr3.5910 | PMID 35662780

AbstractDevelopment of pemphigus foliaceus (PF) following SARS‐CoV‐2 infection has only been reported in one patient who had received Bamlanivimab and thus might be considered as a drug‐induced case of PF. Here, we reported the first case of PF arising solely after COVID infection without taking any culprit drug.
Dexamethasone or prednisone: Which one should be the corticosteroid of choice in patients with pemphigus vulgaris?

Dermatologic Therapy | April 14, 2022 | Volume: 35 | Issue: 7 | Pages: No page available

10.1111/dth.15511 | PMID 35419910

The role of SARS‐CoV‐2 infection and its vaccines in various types of hair loss

Dermatologic Therapy | March 10, 2022 | Volume: 35 | Issue: 6 | Pages: No page available

10.1111/dth.15433 | PMID 35266262

SARS‐CoV‐2 vaccination and practical points in psoriasis patients: A narrative review

Dermatologic Therapy | March 9, 2022 | Volume: 35 | Issue: 5 | Pages: No page available

10.1111/dth.15430 | PMID 35261123